In contrast, Wu et al. found that treatment with a pan-HDAC inhibitor did not alter YAP expression in several SCLC lines, whereas treatment with Entinostat, a benzamide-family HDAC inhibitor that targets the class I subset of HDACs, resulted in YAP induction [30]. The gene discussed is YAP1; the disease is small cell lung carcinoma.